Key statistics
On Monday, Marinus Pharmaceuticals Inc (61Y:FRA) closed at 0.304, 11.76% above the 52 week low of 0.272 set on Nov 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.304 |
---|---|
High | 0.304 |
Low | 0.304 |
Bid | -- |
Offer | -- |
Previous close | 0.302 |
Average volume | 6.58k |
---|---|
Shares outstanding | 55.08m |
Free float | 49.06m |
P/E (TTM) | -- |
Market cap | 17.90m USD |
EPS (TTM) | -2.47 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 07:00 GMT.
More ▼
Press releases
- Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results
- Marinus Pharmaceuticals Announces Topline Results From Phase 3 TrustTSC Trial of Oral Ganaxolone in Tuberous Sclerosis Complex and Commences Process to Explore Strategic Alternatives
- Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting
- Marinus Pharmaceuticals Further Strengthens Intellectual Property Estate with Method of Treatment Patent for ZTALMY® Titration Regimens
- Marinus Pharmaceuticals Announces Podium and Poster Presentations at the Neurocritical Care Society 2024 Annual Meeting
- Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
- Marinus Pharmaceuticals to Highlight Clinical Progress and Commercial Launch Preparedness for ZTALMY® in TSC at Investor and Analyst Day
- Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024
- Marinus Pharmaceuticals to Present at the 2024 Cantor Global Healthcare Conference
More ▼